←
Babur Lateef, MD3,481 posts
Babur Lateef, MD avatar

Babur Lateef, MD

@LateefForVA

Husband, Father, Ophthalmologist, Current Chair of the Prince William County School Board. Youngstown born and raised. Tweets are all my own.

◷ Joined August 2016▧ 428 Photos and videos
Babur Lateef, MD avatar
Babur Lateef, MD@LateefForVA·Oct 3

.@NIHDirector_Jay highlighting the groundbreaking discovery in MS, ALS, and macular degeneration by @UVA @uvahealthnews research Dr Jay Ambati. New treatments are closer than they ever have been for some of the most difficult medical challenges we face.

🔬Traditional treatments for multiple sclerosis (MS) can help mitigate a patient’s symptoms or keep them from returning. Now, new NIH-funded research suggests that a modified drug historically used for treating HIV and Hepatitis B could potentially reverse the disease’s effects. Learn more ➡️ bit.ly/4rwr37x

1:53
Jay Bhattacharya, MD, PhD avatar
⟳ Babur Lateef, MD retweeted
Jay Bhattacharya, MD, PhD@NIHDirector_Jay·Oct 2

🔬Traditional treatments for multiple sclerosis (MS) can help mitigate a patient’s symptoms or keep them from returning. Now, new NIH-funded research suggests that a modified drug historically used for treating HIV and Hepatitis B could potentially reverse the disease’s effects. Learn more ➡️ bit.ly/4rwr37x

1:53
Voight Health avatar
⟳ Babur Lateef, MD retweeted
Voight Health@VoightHealth·Sep 24

Big potential shift in MS research. An experimental drug from Inflammasome Therapeutics (K-9) didn’t just stop further damage in a multiple sclerosis mouse model, it helped animals recover vision and movement they had already lost.

NIH@NIHSep 23

NEWS: Modified HIV drug reverses vision loss and paralysis in multiple sclerosis model. Read the full story ➡️ bit.ly/4rwr37x

Post attachment
Inflammasome Therapeutics avatar
⟳ Babur Lateef, MD retweeted
Inflammasome Therapeutics@InflammasomeTx·Sep 23

We’re excited to showcase a new paper published in Science Translational Medicine on K9 reversing paralysis and vision loss in multiple sclerosis! Read the full article and news release from the NIH below: science.org/doi/10.1126/scit… nih.gov/news-events/news-rel…

Babur Lateef, MD avatar
Babur Lateef, MD@LateefForVA·Sep 24

Congrats to the team @InflammasomeTx and strong work to revolutionize treatments for MS , ALS, macular degeneration and other neurodegenerative diseases!

HHS@HHSGovSep 23

Message to Americans living with multiple sclerosis (MS): There is Hope! Thanks to the groundbreaking research taking place under @POTUS' and @SecKennedy's leadership, a new study by the @NIH has found promising results in reversing pre-existing vision loss and paralysis in MS models. Learn more 👇

Babur Lateef, MD avatar
Babur Lateef, MD@LateefForVA·Jul 30

Inflammation Matters⬇️⬇️⬇️

We’re honored to see Inflammasome Therapeutics highlighted by The New York Times Magazine in its exploration of chronic inflammation and the promise of targeting inflammasomes to treat diseases including geographic atrophy and ALS.   The article discusses our programs for geographic atrophy and ALS and quotes our co-founder, Jayakrishna Ambati:   “This is something that could reach patients literally in the next 18 to 24 months.” We are grateful to see this important area of science and its potential to translate into meaningful therapies for patients receive international attention.   Read the full article: nytimes.com/interactive/2026…

Babur Lateef, MD avatar
Babur Lateef, MD@LateefForVA·Jul 17

Remarkable results for K8, a novel therapeutic for Geographical Atrophy, presented this AM at the American Society of Retina Specialists in Montreal. @InflammasomeTx

Inflammasome Therapeutics announces positive Phase 2 data from the 6-month Geographic Atrophy trial of Kamuvudine-8 (K8). The trial showed up to a 54% efficacy in slowing disease progression, 4-letter visual benefit compared to controls, 0 safety signals, and 3-month injection durability businesswire.com/news/home/2…

Babur Lateef, MD avatar
Babur Lateef, MD@LateefForVA·May 14

Nice piece in @WSJ citing the work done by Dr Ambati and @InflammasomeTx on repurposing drugs. Incredible potential brewing….

Our work on NRTIs and Alzheimer's disease was highlighted today in the Wall Street Journal op-ed "You Can Teach an Old Drug New Tricks," and in the policy report it links to from the University of Chicago & Duke Margolis Institute on pull funding for generic drug repurposing. wsj.com/opinion/you-can-teac… Across 270,000+ patients in two major health databases, NRTIs are HIV drugs that also block inflammasomes and cut Alzheimer's risk by 6-13% per year of treatment, potentially preventing ~1 million new cases annually (Alzheimer's & Dementia). The same inflammasome biology drives diabetes too, where NRTIs reduce risk by 33% (Nature Communications). The next chapter: K8 and K9, our next-gen inflammasome inhibitors (Kamuvudines), are the direct descendants of this work, safer, more potent, and already in clinical trials. UChicago/Duke Margolis pull funding report: marketshaping.uchicago.edu/w… UVA Health on NRTIs & Alzheimer's disease: uvahealth.com/news/hiv-drugs… UVA Health on NRTIs & diabetes: uvahealth.com/news/hiv-drugs…

Babur Lateef, MD avatar
Babur Lateef, MD@LateefForVA·May 3

Incredible work being done @InflammasomeTx on geographic atrophy (macular degeneration) with Dr Ambati! Please check it out!

At Inflammasome Therapeutics, we’re developing new therapies for retinal and neurodegenerative diseases! In the latest episode of Retina Synthesis, Dr. Jayakrishna Ambati, Founder of Inflammasome Therapeutics, discusses Phase 2 clinical trial results for Kamuvudine-8 (K8), a novel inflammasome inhibitor, in Geographic Atrophy. youtu.be/TtIWp3qKe00?si=CS6N…

Babur Lateef, MD avatar
Babur Lateef, MD@LateefForVA·Mar 12

Congratulations to @OPHSWBB Osbourn Park High School Women’s Basketball in @PWCSNews for winning the 2026 State Championship, successfully defending their 2025 title! BACK TO BACK!

FINAL: Osbourn Park 48, Manchester 42. Yellow Jackets repeat as Class 6 champions.

0:28
Virginia Moose Lodges avatar
⟳ Babur Lateef, MD retweeted
Virginia Moose Lodges@VirginiaMoose·Feb 4

“Skill” slot machines have operated for years in violation of state law. Legalizing slot machines in every corner store REWARDS bad actors & sets a terrible precedent for how to do business in Virginia. …and @GovernorVA said the focus was on affordability & cost of living.

Post attachment